期刊文献+

人PPARα受体cDNA全长序列的克隆及测序

Cloning and sequencing of the full-length of human PPARα cDNA
下载PDF
导出
摘要 目的对人过氧化物酶体增殖物激活受体α(hPPARα)全长cDNA序列进行克隆并测序,为构建含hPPARα基因真核表达载体奠定基础。方法通过逆转录-聚合酶链式反应(RT-PCR)从HepG2细胞总RNA克隆hPPARα全长cDNA序列,胶回收目的条带后与pMD19-T载体连接并转化DH5α感受态菌,用BamH I、Sal I双酶切及基因测序筛选鉴定阳性克隆pMD19-hPPARα-T载体中hPPARα基因的完整性和忠实性。结果经酶切和DNA测序证实pMD19-hPPARα-T载体中插入的hPPARα基因序列与GeneBank中提交的序列(NM001001928)一致。结论成功克隆了hPPARα基因,构建了pMD19-hPPARα-T中间载体,为含hPPARα基因真核表达载体的构建奠定了基础。 Objective To clone and sequence the full-length of human PPARa cDNA in order to further construct the eukaryotic expression vector carrying hPPARa gene. Methods hPPARa cDNA was cloned from HepG2 cells total RNA by RT-PCR. The PCR product recovered from gel were ligated with pMD19-T vector and transformed into DH5α competent cell. The integrity and fidelity of hPPARα cDNA sequence inserted in T vector were verified by BamH Ⅰ and Sal Ⅰ double excising and DNA sequencing assays. Results The positive clone T vector plasmid containing correct sequence of hPPARa cDNA were verified by enzyme digestion as well as sequence analysis and was named as pMD19- hPPARα-T vector. The sequence of inserted hPPARa cDNA was in accordance with the corresponding sequence in C, eneBank database (NM001001928). Conclusions Successfully clone hPPARa gene and construct the pMD19-hPPARa-T intermediate vector ,which provide a good basis for further ccnstruct the eukaryotic expression vector carrying hPPARa gene.
出处 《遵义医学院学报》 2006年第4期324-327,共4页 Journal of Zunyi Medical University
基金 国家自然科学基金资助项目(30572353)
关键词 过氧化物酶体增殖物教活受体α CDNA克隆 T载体 测序 Peroxisome proliferator-activated receptor a cDNA clone T vector, sequence
  • 相关文献

参考文献10

  • 1Issemann I,Green S.Activation of a member of the steroid hormone receptor uperfamily by peroxisome proliferators[J].Nature,1990,347(6294):645-650.
  • 2Lalloyer F,Vandewalle B,Percevault F,et al.Peroxisome proliferator-activated receptor α improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets[J].Diabetes,2006,55(6):1605-1613.
  • 3Israelian-Konaraki Z,Reaven PD.Peroxisome proliferatoractivated receptor-alpha and atherosclerosis:from basic mechanisms to clinical implications[J].Cardiology,2005,103(1):1-9.
  • 4Glass CK,Rosenfeld MG..The coregulator exchange in transcriptional functions of nuclear receptors[J].Genes Dev,2000,14(2):121-141.
  • 5Patsouris D,Reddy JK,Müller M,et al.Peroxisome proliferator-activated receptor α mediates the effects of high-fat diet on hepatic gene expression[J].Endocrinology,2006,147(3):1508-1516.
  • 6Schultze AE,Alborn WE,Newton RK,et al.Adininistration of a PPARα agonist increases serum apolipoprotein A-Ⅴ levels and the apolipoprotein A-Ⅴ/apolipoprotein C-Ⅲ ratio[J].J Lipid Res,2005,46(8):1591-1595.
  • 7Ravnskjaer K,Boergesen M,Rubi B,et al.Peroxisome proliferator-activated receptor α(PPARα) potentiates,whereas PPARα attenuates,glucose-stimulated insulin secretion in pancreatic α-cells[J].Endocrinology,2005,146(8):3266 -3276.
  • 8Gizard F,Amant C,Barbier O,et al.PPARα inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a[J].J Clin Invest,2005,115(11):3228-3238.
  • 9Cohen SN,Chang AC.Recircularization and autonomous replication of a sheared R-factor DNA segment in Escherichia coli transformants[J].Proc Natl Acad Sci U S A,1973,70(5):1293-1297.
  • 10黄培堂译.分子克隆实验指南[M](第3版)[M].北京:科学出版社,2002.461-730.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部